CVS HEALTH CORPORATION (CVS) FY2024 Q3 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2024-07-01 to 2024-09-30

Swipe to see the full flow
CVS HEALTH CORPORATION cash flow reconciliation, Jul 1, 2024 through Sep 30, 2024One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Proceeds from sales and maturities of investments → investing reconciliation: $3,216,000,000.00Other → investing reconciliation: $15,000,000.00investing reconciliation → Purchases of investments: $5,896,000,000.00investing reconciliation → Purchases of property and equipment: $670,000,000.00investing reconciliation → Acquisitions (net of cash and restricted cash acquired): $12,000,000.00Commercial paper borrowings (repayments), net → financing reconciliation: $800,000,000.00Proceeds from exercise of stock options → financing reconciliation: $114,000,000.00Other → financing reconciliation: $8,000,000.00Repurchase of common stock → financing reconciliation: $1,000,000.00financing reconciliation → Repayments of long-term debt: $1,669,000,000.00financing reconciliation → Dividends paid: $837,000,000.00financing reconciliation → Payments for taxes related to net share settlement of equity awards: $5,000,000.00Net cash used in operating activities → operating reconciliation: $745,000,000.00Net income → operating reconciliation: $71,000,000.00Other assets → operating reconciliation: $1,391,000,000.00Health care costs payable and other insurance liabilities → operating reconciliation: $1,297,000,000.00Depreciation and amortization → operating reconciliation: $1,161,000,000.00Accounts payable and pharmacy claims and discounts payable → operating reconciliation: $978,000,000.00Restructuring charges (impairment of long-lived assets) → operating reconciliation: $840,000,000.00Stock-based compensation → operating reconciliation: $133,000,000.00operating reconciliation → Accounts receivable, net: $3,784,000,000.00operating reconciliation → Inventories: $1,582,000,000.00operating reconciliation → Other liabilities: $679,000,000.00operating reconciliation → Deferred income taxes and other items: $571,000,000.00Net cash used in financing activities → financing reconciliation: $1,588,000,000.00Net cash used in investing activities → investing reconciliation: $3,347,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $12,820,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $7,140,000,000.00Cash sources and uses → Net cash used in investing activities: $3,347,000,000.00Cash sources and uses → Net cash used in financing activities: $1,588,000,000.00Cash sources and uses → Net cash used in operating activities: $745,000,000.00Net income: $71,000,000.00Net income+$71.00 MDepreciation and amortization: $1,161,000,000.00Depreciation & amortization+$1.16 BStock-based compensation: $133,000,000.00Stock-based compensation+$133.00 MRestructuring charges (impairment of long-lived assets): $840,000,000.00Asset impairments+$840.00 MDeferred income taxes and other items: -$571,000,000.00Deferred taxes & other items−$571.00 MAccounts receivable, net: -$3,784,000,000.00Accounts receivable−$3.78 BInventories: -$1,582,000,000.00Inventories−$1.58 BOther assets: $1,391,000,000.00Other operating assets+$1.39 BAccounts payable and pharmacy claims and discounts payable: $978,000,000.00Accounts payable+$978.00 MHealth care costs payable and other insurance liabilities: $1,297,000,000.00Insurance liabilities+$1.30 BOther liabilities: -$679,000,000.00Other operating liabilities−$679.00 MNet cash used in operating activities: -$745,000,000.00. Cash required to fund net payments.Operating cash−$745.00 Moperating reconciliation: $6,616,000,000.00Commercial paper borrowings (repayments), net: $800,000,000.00Commercial paper, net+$800.00 MProceeds from issuance of short-term loan: $0.00Repayment of short-term loan: $0.00Proceeds from issuance of long-term debt: $0.00Repayments of long-term debt: -$1,669,000,000.00Long-term debt repaid−$1.67 BRepurchase of common stock: $1,000,000.00Common stock repurchases+$1.00 MDividends paid: -$837,000,000.00Dividends paid−$837.00 MProceeds from exercise of stock options: $114,000,000.00Stock option exercises+$114.00 MPayments for taxes related to net share settlement of equity awards: -$5,000,000.00Stock-award tax withholding−$5.00 MOther: $8,000,000.00Other financing, net+$8.00 MNet cash used in financing activities: -$1,588,000,000.00. Cash required to fund net payments.Financing cash−$1.59 Bfinancing reconciliation: $2,511,000,000.00Purchases of investments: -$5,896,000,000.00Investment purchases−$5.90 BAcquisitions (net of cash and restricted cash acquired): -$12,000,000.00Acquisitions, net of cash−$12.00 MProceeds from sales and maturities of investments: $3,216,000,000.00Marketable securities proceeds+$3.22 BOther: $15,000,000.00Other investing, net+$15.00 MPurchases of property and equipment: -$670,000,000.00PP&E purchases−$670.00 MNet cash used in investing activities: -$3,347,000,000.00. Cash required to fund net payments.Investing cash−$3.35 Binvesting reconciliation: $6,578,000,000.00Cash sources and uses: $12,820,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $12,820,000,000.00Beginning cash$12.82 BEnding cash: Cash, cash equivalents, and restricted cash: $7,140,000,000.00Ending cash$7.14 BCASH RECONCILIATIONInvestingflowsFinancingflowsOperatingflowsFree cash flow−$1.42 BOperating cash − cash spent on PP&ECash flow / Net income−10.49×Operating cash flow ÷ net incomeNet cash change−$5.68 BEnding cash − beginning cash
Chart details

CVS HEALTH CORPORATION cash flow reconciliation, Jul 1, 2024 through Sep 30, 2024

Cash flows for Jul 1, 2024 through Sep 30, 2024. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Jun 30, 2024. Ending cash: Sep 30, 2024. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Jun 30, 2024
12,820,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
negative 745,000,000 US dollars. Net cash used.
Net income
71,000,000 US dollars
Depreciation and amortization
1,161,000,000 US dollars
Stock-based compensation
133,000,000 US dollars
Restructuring charges (impairment of long-lived assets)
840,000,000 US dollars
Deferred income taxes and other items
negative 571,000,000 US dollars
Accounts receivable, net
negative 3,784,000,000 US dollars
Inventories
negative 1,582,000,000 US dollars
Other assets
1,391,000,000 US dollars
Accounts payable and pharmacy claims and discounts payable
978,000,000 US dollars
Health care costs payable and other insurance liabilities
1,297,000,000 US dollars
Other liabilities
negative 679,000,000 US dollars
Investing activities
negative 3,347,000,000 US dollars. Net cash used.
Purchases of investments
negative 5,896,000,000 US dollars
Acquisitions (net of cash and restricted cash acquired)
negative 12,000,000 US dollars
Proceeds from sales and maturities of investments
3,216,000,000 US dollars
Other
15,000,000 US dollars
Purchases of property and equipment
negative 670,000,000 US dollars
Financing activities
negative 1,588,000,000 US dollars. Net cash used.
Commercial paper borrowings (repayments), net
800,000,000 US dollars
Proceeds from issuance of short-term loan
0 US dollars
Repayment of short-term loan
0 US dollars
Proceeds from issuance of long-term debt
0 US dollars
Repayments of long-term debt
negative 1,669,000,000 US dollars
Repurchase of common stock
1,000,000 US dollars
Dividends paid
negative 837,000,000 US dollars
Proceeds from exercise of stock options
114,000,000 US dollars
Payments for taxes related to net share settlement of equity awards
negative 5,000,000 US dollars
Other
8,000,000 US dollars
Operating adjustment reconciliation
6,616,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
2,511,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
6,578,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Sep 30, 2024
7,140,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
12,820,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 5,680,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
−10.49×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
negative 745,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
670,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
negative 1,415,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income or operating cash is negative. The full signed reconciliation is retained: losses remain deductions, and any negative operating-cash total enters the junction from the cash pool. No positive direct-income connection is implied.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: negative 745,000,000 US dollars minus 670,000,000 US dollars equals negative 1,415,000,000 US dollars.
CVS HEALTH CORPORATION (CVS) FY2024 Q3 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!